UK Parliament home

This petition was submitted during the 2015 to 2017 Parliament

View other petitions from this Parliament

Closed Ensure the Pfizer and Flynn Pharma CMA fines are used solely to improve NHS care

Closed on

Pharmaceutical companies Pfizer and Flynn Pharma have been fined a total of £89.4m by the Competition and Marketing Authority for exploiting a monopoly position over the marketing of the epilepsy drug Epanutin. Their actions have cost the NHS an estimated £44m per year for the last 4 years.

The cost of this scandal has been entirely born by the NHS, and if all the fines are returned to the NHS it will still fall short of the £176m extra the NHS has had to pay for this vital drug. Patients with epilepsy have been most affected, and so some of the money should be used to employ Epilepsy Nurses to improve epilepsy care. See https://binscombedoctorblog.wordpress.com/2012/10/06/the-marketing-of-epanutin-re-energising-a-product-for-an-underserved-population-or-big-pharma-behaving-badly/

1,336 signatures

Show on a map

10,000

Petition progress

View all updates for this petition, with the most recent first.

  • Petition closed

  • Petition published

    This petition can now be signed.

    If this petition gets 10,000 signatures, government will respond to it.

    If this petition gets 100,000 signatures, it will be considered for debate in Parliament.

    This petition will stay open until 3 May 2017.